Who To Contact
Baptist MD Anderson
Cancer Center
1301 Palm Avenue
Jacksonville, FL 32207
Andres Alvarez, MD, PhD, EMHA
Research Director
Baptist MD Anderson Clinical Trials
Clinical Trial ID: NCT06615479
Phase 3, Randomized, Open-Label, Multicenter Study to Compare the Efficacy and Safety of Arlocabtagene Autoleucel (BMS-986393), a GPRC5D-directed CAR-T Cell Therapy, Versus Standard Regimens in Adult Participants with Relapsed or Refractory and Lenalidomide exposed Multiple Myeloma (QUINTESSENTIAL-2)
Status
Open
Conditions
Multiple Myeloma
Phases
3 (Cancer Control)
Age Group
Adult
Main Investiagtor
Norkin, Maxim
Practice
Myeloma
Scope
National
Participating Institutions
Baptist MD Anderson Cancer Center
Nct ID Number
NCT06615479
Secondary Trial ID Number
CA0881007
Keywords
Treatment